Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients
- PMID: 25041708
- PMCID: PMC4223715
- DOI: 10.1186/1471-2334-14-405
Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients
Abstract
Background: Transient elastography (TE) is widely used for non-invasive assessment of liver fibrosis in HIV-HCV co-infected patients. TE, however, cannot determine liver morphology. Acoustic radiation force impulse (ARFI) imaging is a novel procedure enabling assessment of liver fibrosis during a conventional ultrasonographic examination. This study evaluated the correlation between liver fibrosis measurements by TE and ARFI.
Methods: Each of 46 HIV-HCV patients underwent both ARFI and TE within 6 months. Patients were evaluated by the "equivalent METAVIR" scoring system, using previously established cut-off values. Agreements between the ARFI and TE scores were estimated by Kappa coefficients, with Kappa values ≥0.40, ≥0.60, and ≥0.80 defined as moderate, good and very good agreement, respectively.
Results: ARFI and TE yielded "Equivalent Metavir" fibrosis scores of F1 in 26 and 31 patients, respectively; F2 in nine and seven, respectively; F3 in three and two, respectively; and F4 in eight and six, respectively. The two methods showed very good agreement in predicting overall stages [Kappa = 0.82] and for F ≥3 [Kappa = 0.80] and moderate agreement in predicting significant fibrosis F ≥2 [Kappa = 0.50]. Morphologic ultrasound analysis concomitant to ARFI detected two hepatocarcinomas.
Conclusions: ARFI showed promising results in the non-invasive assessment of liver fibrosis in HIV-HCV patients, with liver fibrosis staging similar to that of TE. Moreover, ARFI can assess morphology and fibrosis during the same session.
Figures


Similar articles
-
Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice.J Ultrasound Med. 2018 Jan;37(1):113-121. doi: 10.1002/jum.14312. Epub 2017 Jul 17. J Ultrasound Med. 2018. PMID: 28715086
-
Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies.Ultraschall Med. 2011 Jan;32 Suppl 1:S46-52. doi: 10.1055/s-0029-1245360. Epub 2010 Jul 5. Ultraschall Med. 2011. PMID: 20603783
-
Is it better to use two elastographic methods for liver fibrosis assessment?World J Gastroenterol. 2011 Sep 7;17(33):3824-9. doi: 10.3748/wjg.v17.i33.3824. World J Gastroenterol. 2011. PMID: 21987625 Free PMC article.
-
Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis.Liver Int. 2013 Sep;33(8):1138-47. doi: 10.1111/liv.12240. Epub 2013 Jul 16. Liver Int. 2013. PMID: 23859217 Review.
-
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis.J Viral Hepat. 2012 Feb;19(2):e212-9. doi: 10.1111/j.1365-2893.2011.01537.x. Epub 2011 Oct 30. J Viral Hepat. 2012. PMID: 22239521
Cited by
-
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection.PLoS One. 2015 Feb 3;10(2):e0116768. doi: 10.1371/journal.pone.0116768. eCollection 2015. PLoS One. 2015. PMID: 25646812 Free PMC article.
-
Diagnostic Performance of Acoustic Radiation Force Impulse Imaging in Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study.Indian J Radiol Imaging. 2022 Aug 30;32(3):287-293. doi: 10.1055/s-0042-1755251. eCollection 2022 Sep. Indian J Radiol Imaging. 2022. PMID: 36177272 Free PMC article.
-
Non-invasive evaluation of liver fibrosis by acoustic radiation force impulse and aminotransferase:platelet ratio index in chronic hepatitis C.World J Hepatol. 2016 Feb 8;8(4):263-4. doi: 10.4254/wjh.v8.i4.263. World J Hepatol. 2016. PMID: 26855695 Free PMC article.
-
Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C.World J Hepatol. 2017 Mar 18;9(8):436-442. doi: 10.4254/wjh.v9.i8.436. World J Hepatol. 2017. PMID: 28357031 Free PMC article.
-
Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective.Lipids Health Dis. 2025 Jan 7;24(1):5. doi: 10.1186/s12944-024-02396-3. Lipids Health Dis. 2025. PMID: 39773634 Free PMC article. Review.
References
-
- Rosenthal E, Poiree M, Pradier C, Perronne C, Salmon-Ceron D, Geffray L, Myers RP, Morlat P, Pialoux G, Pol S, Cacoub P. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) Aids. 2003;17:1803–1809. - PubMed
-
- Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27–34. - PubMed
-
- Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, Cargnel A, Mauss S, Dieterich D, Moreno S, Ferrari C, Poynard T, Rockstroh J. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. Aids. 2002;16:813–828. - PubMed
-
- Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-Ceron D, Degott C, Cacoub P, Perronne C. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. Jama. 2004;292:2839–2848. - PubMed
-
- Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004;351:451–459. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous